ipglycermides (National Institutes of Health/National Center for Advancing Translational Sciences/University of Tokyo)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameipglycermides (National Institutes of Health/National Center for Advancing Translational Sciences/University of Tokyo)
Drug Alias Nameipglycermide BCe-2
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPhosphoglycerate Mutase inhibitors
TargetsPhosphoglycerate Mutase
Therapy Area/IndicationsParasitic DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsParasitic DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A